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Abstract Widely accepted quality indicators for head-
ache care would provide a basis not only for assessment of
care but also, and more importantly, for its improvement.
The objective of the study was to identify and summarize
existing information on such indicators: specifically, did
indicators exist, how had they been developed, what
aspects of headache care did they relate to and how and
with what utility were they being used? A systematic
review of the medical literature was performed. A total of
32 articles met criteria for inclusion. We identified 55
existing headache quality indicators of which 37 evaluated
processes of headache care. Most were relevant only to
specific populations of patients and to care delivered in
high-resource settings. Indicators had been used to describe
overall quality of headache care at a national level, but not
systematically applied to the evaluation and improvement
of headache services in other settings. Some studies had
evaluated the use of existing disability and quality of life
instruments, but their findings had not been incorporated
into quality indicators. Existing headache care quality
indicators are incomplete and inadequate for purpose. They
emphasize processes of care rather than structure or out-
comes, and are not widely applicable to different levels and
locations of headache care. Furthermore, they do not fully
incorporate accepted evidence regarding optimal methods
of care. There is a clear need for consensus-based indica-
tors that fully reflect patients’ and public-health priorities.
Ideally, these will be valid across cultures and health-care
settings.
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Introduction
Despite the high prevalence of recurrent headache disor-
ders—principally migraine and tension-type headache—
and the substantial burden of public ill-health they generate
[1, 2], there are considerable variations worldwide in the
nature, scope, organization, quantity and quality of medical
care provided for these illnesses. At the same time, there is
good evidence that optimal care is rarely achieved. There
are multiple clinical, social and political barriers to both
provision of and access to effective headache care, a recent
publication by the World Health Organization stated: ‘‘The
facts and figures presented … illuminate the worldwide
neglect of a major cause of public ill-health and reveal
the inadequacies of responses to it in countries throughout
the world’’ [2]. In addition, and standing as a barrier to
improvement, it is not certain that there is a universal view
of what optimal headache services should look like, or,
indeed, of the meaning in this context of ‘‘optimal’’.
It is axiomatic that health-care systems should aspire to
high quality of care, but progress toward this requires that
quality can be assessed. Before this is possible, ‘‘quality’’
must first be defined. Donabedian [3], in a view now widely
endorsed, suggested that quality of care should be consid-
ered in each of three domains: ‘‘structure’’ (the attributes of
the settings in which care occurs); ‘‘process’’ (the giving and
receiving of care); and ‘‘outcome’’ (the effects that care has
on health status). Donabedian [4] also described seven
attributes that in his view collectively defined health-care
quality: efficacy, effectiveness, efficiency, optimality,
acceptability, legitimacy and equity. A definition of quality
of health care offered by the US Institute of Medicine (IOM)
put the emphasis on outcomes: the degree to which health-
care services for individuals and populations increase the
likelihood of desired health outcomes and are consistent
with current professional knowledge [5]. The IOM specified
six attributes of quality, differing somewhat from Donabe-
dian’s seven: safety, timeliness, effectiveness, efficiency,
equity and patient/family-centerdness.
What are needed for services delivering headache care are
agreed and widely accepted quality measures. Their appli-
cation to existing services might, by establishing standards of
care, providing benchmarks and revealing deficiencies,
motivate and guide improvements. Their employment will
bring clarity of purpose to initiatives aimed at developing
services where none exist. As a project within the Global
Campaign against Headache [6, 7], which seeks both to
develop and improve services, we performed a systematic
literature review with the aim of identifying and summarizing
existing information on quality indicators for headache care.
Specifically, our questions were: did indicators exist, how had
they been developed, what aspects of headache care did they
relate to and how and with what utility were they being used?
Methods
Search strategy
During 2009 we searched Medline, EMBASE and
CINAHL without language restrictions for relevant articles
using the search terms ‘‘headache disorders’’ and ‘‘health
care quality’’ for both title and text words. We combined
the individual search results using the Boolean operator
‘‘AND’’. We extended the search to articles containing text
words ‘‘headache care*.tw’’ or ‘‘headache service*.tw’’ in
order to ensure identification of all relevant articles. The
thesaurus terms and text words used for these searches are
shown in Table 1. The search was limited to articles from
1988 onwards, this being the year in which universally
accepted definitions of headache disorders were first pub-
lished [8]. We updated the search in February 2012 and
found no new articles specifically related to the definition
of quality or to quality indicators in the context of head-
ache care. All identified articles were transferred to
Reference Manager, a bibliographic software program.
Inclusion and exclusion criteria
Two of the authors (SP and MP) screened titles and
abstracts for relevance using predefined inclusion and
exclusion criteria. Studies were included if they reported
the development or application of quality indicators for
headache care or evaluated other aspects of service provi-
sion for headache disorders. Articles unrelated to primary
headache disorders, review articles, drug treatment studies,
case reports, letters and comments, and papers that were
not written in English were excluded. We obtained full-text
versions of papers selected for further review, and again
evaluated these against our inclusion and exclusion criteria.
Any disagreements were resolved by consensus. Figure 1
shows the flow of studies through the review.
Data extraction and analysis
A data extraction form was developed to summarize the
relevant results of the studies selected. Formal statistical
analysis was not possible because of the heterogeneity of
evidence and measures in the selected articles, so a nar-
rative synthesis of the findings was prepared.
Results
A total of 32 studies met criteria for inclusion in the
review. Four [9–12] reported development of quality
indicators for use in headache-service delivery; 28 [13–40]
(listed in Table 2) evaluated aspects of headache care
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quality in a variety of settings, but did not employ formal
quality measures to do so.
Development of quality indicators
Tables 3 and 4 list the characteristics and results of the
four studies that reported on the development of a total of
55 quality indicators. These indicators are categorized
according to domain of application: structure, process or
outcome of headache care. Within these domains are sub-
domains into which they are further categorized. In fact,
none of the studies developed indicators of quality of
structural aspects of headache care. All, however, selected
indicators of process, and 36 of the 37 process measures
evaluated diagnostic or treatment procedures (for exam-
ple, the use of specific diagnostic procedures when certain
features were present in history or physical examination,
or the prescription of specific medications for certain
types of headache). Such process indicators commonly
use ‘‘if–then’’ statements, and therefore do not apply to all
patients evaluated for headache. Only two studies devel-
oped indicators of outcome of headache care: a total of 18
indicators, focusing on frequency and severity of head-
aches or on uptake of care. None of these outcome indi-
cators evaluated disability, quality of life or patients’
satisfaction with care.
Table 1 Search terms in the literature review
MEDLINE EMBASE CINAHL
Thesaurus terms for
‘headache’
Headache disorders/
Headache disorders primary/
Migraine disorders/
Migraine with aura/
Migraine without aura/
Tension type headache/
Headache/
Primary headache/
Migraine/
Tension headache/
Chronic daily headache/
Headache/
Migraine/
Tension headache/
Text words for ‘headache’
(Title & Abstract)
Chronic daily headache*.tw.
Migraine*.tw.
Tension headache*.tw.
Tension type headache*.tw.
TTH*.tw.
CDH*.tw.
Chronic daily headache*.tw.
Migraine*.tw.
Tension headache*.tw.
Tension type headache*.tw.
TTH*.tw.
CDH*.tw.
Chronic daily headache*
Migraine*
Tension headache*
Tension type headache*
TTH*
CDH*
Thesaurus terms for
‘health care quality’
Quality of health care/
Quality assurance health care/
Total quality management/
Outcome and process assessment
(health care)/
Quality indicators, health care/
Peer review, health care/
Programme evaluation/
Bench marking/
Clinical audit/
Medical audit/
Nursing audit/
Health care quality/
Quality indicators,
health care/
Peer review, health care/
Medical audit/
Quality assessment/
Clinical Indicators/
Nursing audit/
Outcome assessment/
Outcome assessment
information set/
Peer review/
Process assessment (health care)/
Program evaluation/
Quality of health Care/
Quality of nursing care/
Quality assurance/
Quality improvement/
Evaluation and quality
improvement program/
Benchmarking/
Quality management organizational/
Text words for ‘healthcare
quality’
(Title & Abstract)
Health service* research*.tw.
Health service* evaluation*.tw.
Continuous quality
improvement*.tw.
Health service* research*.tw.
Health service* evaluation*.tw.
Nursing audit*.tw.
Continuous quality improvement*
Health service* research*
Health service* evaluation*
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All four studies were conducted in developed western
countries, but they varied in their goals and in their
methods of indicator development. Two [9, 10] aimed to
evaluate overall quality of care provided at a national level
for a number of common conditions, headache among
them. They employed elaborate consensus methods for the
development of indicators focused on process, since the
scope of the projects made it unfeasible to collect outcome
information. The other two studies [11, 12] had the more
specific goal of evaluating migraine care, either within
health plans or within a specialty clinic. They employed
less extensive, more practical methods to develop quality
indicators, but concentrated on treatment outcomes. These
four studies are the key, and we describe them below in
more detail.
McGlynn et al. [10] developed quality indicators for 30
acute and chronic conditions; the purpose was to assess
overall quality of medical care provided to adults in the
United States (US). Marshall et al. [9] developed quality
indicators for 18 diseases in a project to assess quality of
health care delivered to adults in primary care in the United
Kingdom (UK). In both studies, the process of developing
quality indicators began with a literature review. McGlynn
et al. [10] then used a modified Delphi method to develop a
final set of indicators. US experts in each disease area rated
putative quality indicators on a 9-point scale from 1 (‘‘not
valid’’) to 9 (‘‘very valid’’). Only those with a median
composite score of C7 were selected. Similar methods
were employed by Marshall et al. [9]. UK primary-care
experts rated putative indicators on a 9-point validity scale,
and also rated the necessity of including such information
in patient records. Only those that achieved mean scores of
C8 for validity and C6 for necessity scale were selected.
Leas et al. [12] developed a set of 20 quality of care
measures specific to migraine—the only set of indicators to
include both process and outcome measures. Existing
measures were identified through a literature review and
other candidate measures through telephone interviews
with leaders in migraine care, health-care purchasing and
managed care. An advisory board of experts then discussed
all putative measures and, by consensus, selected a final set
of indicators for testing. In contrast to those developed by
McGlynn and by Marshall, this set of quality indicators
included a number that evaluated the costs and outcomes of
treatment.
Ferrari et al. [11] developed a set of quality indicators
for headache care in conjunction with the staff of a spe-
cialist headache center and a quality assurance office. The
goal of these indicators was to ensure the provision of
consistent, high-quality care within a specialized headache
treatment center. This set of indicators did not include any
measures of headache care structure or process but instead
focused exclusively on specific aspects of treatment
outcome.
Evaluation of specific aspects of headache care
Table 2 lists the 28 studies [13–40] that assessed specific
components of headache care associated with quality,
without employing formal quality indicators. It also indi-
cates the domains of quality (and sub-domains) addressed
by each. All these studies were conducted in highly re-
sourced locations, but evaluated strategies and aspects of
care delivered in a range of settings by different practi-
tioners. Four studies [18, 23, 28, 30] were conducted in
primary care, three [14, 36, 37] in intermediate care, where
treatment was provided by general practitioners with a
special interest in headache, and one [20] in a setting where
specialist nurses provided care. Six studies [21, 22, 31,
38–40] were conducted in specialty headache clinics, one [35]
in an inpatient treatment setting, and five [13, 15, 17, 32,
33] evaluated headache care in emergency departments.
Embase: 340 
citations 
identified  
Medline: 190 
citations 
identified  
CINAHL: 60 
citations 
identified  
599 citations 
identified 
471 citations 
screened by title 
and abstract 
39 full text 
articles retrieved 
and screened 
128 duplicate citations 
excluded
7 articles excluded: did 
not meet inclusion 
criteria
32 full text 
articles included 
in the review 
432 citations excluded: 
• 334 not relevant to 
headache;
• 42 opinion papers; 
• 26 drug treatment 
evaluation studies; 
• 23 not relevant to 
quality measures 
• 7 not published in 
English 
Fig. 1 Flow of studies through the review
440 J Headache Pain (2012) 13:437–447
123
T
a
b
le
2
S
tu
d
ie
s
(n
=
2
8
)
(i
d
en
ti
fi
ed
b
y
fi
rs
t
au
th
o
r)
ev
al
u
at
in
g
h
ea
d
ac
h
e
ca
re
co
m
p
o
n
en
ts
as
so
ci
at
ed
w
it
h
q
u
al
it
y
A
u
th
o
r
P
ro
ce
ss
O
u
tc
o
m
e
D
ia
g
n
o
si
s
T
re
at
m
en
t
M
an
ag
em
en
t
S
er
v
ic
es
C
li
n
ic
al
sy
m
p
to
m
s
Im
p
ac
t
S
at
is
fa
ct
io
n
A
g
o
st
o
n
i
[1
3
]
D
ia
g
n
o
st
ic
ac
cu
ra
cy
B
el
am
[1
4
]
Im
p
ac
t
Q
u
al
it
y
o
f
li
fe
B
ig
al
[1
5
]
D
ia
g
n
o
st
ic
ra
te
s
In
v
es
ti
g
at
io
n
s
B
lu
m
en
fe
ld
[1
6
]
P
ro
p
h
y
la
ct
ic
P
at
ie
n
t
ed
u
ca
ti
o
n
C
o
n
su
lt
at
io
n
s
Q
u
al
it
y
o
f
li
fe
P
h
y
si
ci
an
s’
sa
ti
sf
ac
ti
o
n
B
lu
m
en
th
al
[1
7
]
D
ia
g
n
o
st
ic
ac
cu
ra
cy
A
cu
te
H
ea
d
ac
h
e
se
v
er
it
y
C
am
p
in
h
a-
B
ac
o
te
[1
8
]
P
at
ie
n
t
ed
u
ca
ti
o
n
R
ec
o
g
n
it
io
n
o
f
tr
ig
g
er
s
H
ea
d
ac
h
e
se
v
er
it
y
H
ea
d
ac
h
e
fr
eq
u
en
cy
E
co
n
o
m
ic
b
u
rd
en
W
o
rk
p
ro
d
u
ct
iv
it
y
P
at
ie
n
t
sa
ti
sf
ac
ti
o
n
C
la
rk
e
[1
9
]
D
ia
g
n
o
st
ic
ac
cu
ra
cy
In
v
es
ti
g
at
io
n
s
C
la
rk
e
[2
0
]
D
ia
g
n
o
st
ic
ac
cu
ra
cy
In
v
es
ti
g
at
io
n
s
T
re
at
m
en
t
g
en
er
al
ly
H
ea
d
ac
h
e
im
p
ro
v
em
en
t
o
r
d
et
er
io
ra
ti
o
n
D
av
ie
s
[2
2
]
In
v
es
ti
g
at
io
n
s
P
ai
n
se
v
er
it
y
P
at
ie
n
t
sa
ti
sf
ac
ti
o
n
D
o
w
so
n
[2
2
]
D
ia
g
n
o
st
ic
ra
te
s
In
v
es
ti
g
at
io
n
s
A
cu
te
P
ro
p
h
y
la
ct
ic
E
ls
n
er
[2
3
]
D
ia
g
n
o
st
ic
ra
te
s
P
h
y
si
ci
an
ed
u
ca
ti
o
n
P
ai
n
se
v
er
it
y
G
ah
ir
[2
4
]
C
o
n
su
lt
at
io
n
s
(G
P
an
d
p
h
ar
m
ac
is
t)
G
ah
ir
[2
5
]
C
o
n
su
lt
at
io
n
s
(e
m
er
g
en
cy
d
ep
ar
tm
en
t)
H
ar
p
o
le
[2
6
]
A
cu
te
P
ro
p
h
y
la
ct
ic
R
ef
er
ra
ls
D
is
ab
il
it
y
Q
u
al
it
y
o
f
li
fe
P
at
ie
n
t
sa
ti
sf
ac
ti
o
n
H
ar
p
o
le
[2
7
]
P
ro
p
h
y
la
x
is
C
o
n
su
lt
at
io
n
s
(e
m
er
g
en
cy
d
ep
ar
tm
en
t)
D
is
ab
il
it
y
K
ar
li
[2
8
]
D
ia
g
n
o
st
ic
ac
cu
ra
cy
A
cu
te
P
ro
p
h
y
la
x
is
P
h
y
si
ci
an
ed
u
ca
ti
o
n
L
ar
n
er
[2
9
]
P
re
sc
ri
p
ti
o
n
ra
te
s
C
o
n
su
lt
at
io
n
s
(G
P
)
J Headache Pain (2012) 13:437–447 441
123
T
a
b
le
2
co
n
ti
n
u
ed
A
u
th
o
r
P
ro
ce
ss
O
u
tc
o
m
e
D
ia
g
n
o
si
s
T
re
at
m
en
t
M
an
ag
em
en
t
S
er
v
ic
es
C
li
n
ic
al
sy
m
p
to
m
s
Im
p
ac
t
S
at
is
fa
ct
io
n
L
at
in
o
v
ic
[3
0
]
P
re
sc
ri
p
ti
o
n
ra
te
s
C
o
n
su
lt
at
io
n
s
(G
P
)
R
ef
er
ra
ls
M
ag
n
u
ss
o
n
[3
1
]
H
ea
d
ac
h
e
fr
eq
u
en
cy
H
ea
d
ac
h
e
se
v
er
it
y
D
is
ab
il
it
y
Q
u
al
it
y
o
f
li
fe
M
ai
ze
ls
[3
2
]
D
ia
g
n
o
st
ic
ra
te
s
P
re
sc
ri
p
ti
o
n
ra
te
s
A
cu
te
P
ro
p
h
y
la
x
is
O
T
C
u
se
C
o
n
su
lt
at
io
n
s
(e
m
er
g
en
cy
d
ep
ar
tm
en
t)
M
ai
ze
ls
[3
3
]
D
ia
g
n
o
st
ic
ra
te
s
A
cu
te
m
ed
ic
at
io
n
P
re
sc
ri
p
ti
o
n
ra
te
s
M
at
ch
ar
[3
4
]
P
at
ie
n
t
ed
u
ca
ti
o
n
D
is
ab
il
it
y
Q
u
al
it
y
o
f
li
fe
D
ep
re
ss
io
n
M
el
ch
ar
t
[3
5
]
D
ia
g
n
o
st
ic
ra
te
s
M
ed
ic
at
io
n
u
se
P
ai
n
in
te
n
si
ty
P
ai
n
fr
eq
u
en
cy
F
u
n
ct
io
n
al
ab
il
it
y
Q
u
al
it
y
o
f
li
fe
H
ea
lt
h
-r
el
at
ed
b
eh
av
io
r
O
ff
re
d
y
[3
6
]
P
at
ie
n
t
sa
ti
sf
ac
ti
o
n
R
id
sd
al
e
[3
7
]
C
o
st
o
f
se
rv
ic
e
P
at
ie
n
t
sa
ti
sf
ac
ti
o
n
S
o
o
n
[3
8
]
D
ia
g
n
o
st
ic
ra
te
s
A
cu
te
m
ed
ic
at
io
n
P
ro
p
h
y
la
ct
ic
m
ed
ic
at
io
n
D
is
ab
il
it
y
Q
u
al
it
y
o
f
li
fe
V
in
ce
n
t
[3
9
]
D
ia
g
n
o
st
ic
ac
cu
ra
cy
P
ro
p
h
y
la
ct
ic
m
ed
ic
at
io
n
Z
ee
b
er
g
[4
0
]
D
ia
g
n
o
st
ic
ra
te
s
A
cu
te
m
ed
ic
at
io
n
P
ro
p
h
y
la
ct
ic
m
ed
ic
at
io
n
R
ef
er
ra
ls
H
ea
d
ac
h
e
fr
eq
u
en
cy
T
h
e
q
u
al
it
y
d
o
m
ai
n
‘s
tr
u
ct
u
re
’
is
n
o
t
re
p
re
se
n
te
d
in
th
e
ta
b
le
as
n
o
n
e
o
f
th
e
ar
ti
cl
es
ad
d
re
ss
ed
th
is
d
o
m
ai
n
O
T
C
o
v
er
-t
h
e-
co
u
n
te
r
m
ed
ic
at
io
n
442 J Headache Pain (2012) 13:437–447
123
Four studies [17, 19, 28, 39] assessed diagnostic accuracy,
while eight [16, 18, 23, 26, 27, 31, 34, 35] evaluated the
effects of specific strategies of headache management.
Only two of the studies [31, 34] included a control group;
one of these [34] was a randomized clinical trial. Some of
the studies evaluated outcomes using existing general or
headache-specific disability or quality of life instruments.
Table 5 (available on-line) documents the study charac-
teristics in detail.
We found no studies that reported on the reliability,
validity, practicality or implementation of any of the 55
indicators.
Discussion
While many quality indicators have been developed to
evaluate headache care, evidence regarding their reliability,
validity and practicality is lacking. They emphasize pro-
cesses of care rather than outcomes, and ignore structure.
Most cover areas of routine assessment, but do not clearly
specify the tool or process to be used in evaluation. Others
describe desirable treatment in broad terms, including
diagnosis, management or administration of particular tests
or drugs. None of the identified measures report inter-rater
reliability or other psychometric properties. They are not
clearly applicable to different levels and locations of
headache care. There is no evidence that any of them have
been used for quality improvement, although this is pre-
sumably the purpose for which they were developed.
The process of developing quality indicators was not, in
any of the studies, begun with, or therefore informed by, an
agreed definition of ‘‘quality’’. What is surprising is that
neither did these studies attempt to construct a definition, in
the specific context of headache care, as a prerequisite for
developing indicators of it. While quality is important in
health care for any condition, and may to that extent have a
general definition, there are aspects of it that are specific to
or of particular importance in headache care. Furthermore,
it is not clear that a universally accepted general definition of
quality of care does exist; even its attributes are not wholly
agreed [4]. At issue here is whose perspectives matter in the
meaning and assessment of health-care quality: patients’,
health-care providers’ or payers’? Assuming they all do to
an extent, and they are not perfectly aligned, which have
priority? Quality is not necessarily coupled to financing:
there is no direct relationship between better outcomes and
the amount spent on health care [41]. Improving the quality
of care for headache disorders goes beyond better diagnosis
and good treatment, since large numbers of people with
headache do not consult doctors and hence will not benefit
from improvements in care processes. There is clear evi-
dence of high barriers to care [2], and the need to dismantle
them is high on the agenda for headache-service quality
improvement. Sorting out these issues appears to be a pre-
requisite for developing quality indicators for headache
services, but it has not been done.
Our study has strengths: the systematic nature of the
literature search and review and the incorporation of
information from studies that provided indirect evidence
relevant to the development of quality indicators. Its main
limitation was that we were able to search only for publicly
available quality indicators and implementation studies: it
is possible that insurance companies or other health man-
agement organizations have developed, validated and
implemented proprietary quality indicators that have not
been published. Of course, if such indicators exist, it might
be asked whose perspective(s) they reflect.
In conclusion, we identified a number of studies provid-
ing evidence of the value of specific types, strategies and
measures of headache treatment, but much further work is
needed to incorporate these findings into the development of
valid and practical quality indicators. There is no agreed
definition of ‘‘quality’’ of headache care, and no considered
view on how the non-aligned perspectives of different
stakeholders in headache care should be placed in order of
Table 3 Quality domains for which indicators were developed within the four studies
Quality domain Sub-domain Indicators developed (n)
McGlynn et al. [10] Marshall et al. [9] Leas et al. [12] Ferrari et al. [11]
Structure 0 0 0 0
Process Diagnosis 13 0 5 0
Treatment 8 4 6 0
Referral for care 0 1 0 0
Outcome Headache severity and frequency 0 0 0 6
Disability 0 0 0 0
Quality of life 0 0 0 0
Satisfaction with care 0 0 0 0
Uptake of care 0 0 9 3
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Table 4 Existing headache quality indicators (developed within the four studies)
Domain Sub-domain Quality indicator(s)
McGlynn et al. [10]
Diagnosis History-taking Patients with new onset headache should be asked about:
(1) the location of the pain
(2) their associated symptoms
(3) their temporal profile
(4) the degree of severity of the headache
(5) family history of headache
(6) any possible aggravating or alleviating factors
Physical examination Patients with new onset headache should have an examination evaluating:
(1) the cranial nerves
(2) the fundi
(3) deep tendon reflexes
(4) their blood pressure
Investigations (1) CT or MRI scanning is indicated in patients with new onset headache and an abnormal neurological
examination
(2) CT or MRI scanning is indicated in patients with new onset headache and severe headache
(3) Skull X-rays should not be part of an evaluation for headache
Treatment Acute (1) Patients with acute mild migraine or tension headache should have tried aspirin, Tylenol, or other
nonsteroidal anti-inflammatory agents before being offered any other medication
(2) For patients with acute moderate or severe migraine headache, one of the following should have been
tried before any other agent is offered: ketorolac, sumatriptan, dihydroergotamine, ergotamine,
chlorpromazine, or metoclopramide
(3) Recurrent moderate or severe tension headache should be treated with a trial of tricyclic
antidepressant agents, if there are no medical contraindications to use
(4) Sumatriptan and ergotamine should not be concurrently administered
(5) Opioid agonists and barbiturates should not be first-line therapy for migraine or tension headaches
(6) Sumatriptan and ergotamine should not be given in patients with a history of uncontrolled
hypertension
(7) Sumatriptan and ergotamine should not be given in patients with a history of ischemic heart disease or
angina
Prophylactic (1) If patients have more than two moderate to severe migraine headache each month, then prophylactic
treatment with one of the following agents should be offered: b-blockers, calcium channel blockers,
tricyclic antidepressants, naproxen, aspirin, fluoxetine, valproate, or cyproheptadine
Referral None
Outcome None
Marshall et al. [9]
Diagnosis None
Treatment Acute (1) Sumatriptan should not be prescribed for migraine in patients with angina
Prophylactic (1) Prophylaxis treatment should be offered in patients with severe and disabling migraine
(2) The following agents should be prescribed as first line for prophylaxis of migraine unless
contraindicated; beta blockers, tricyclic antidepressants, pizotifen
(3) Beta blockers should not be prescribed for migraine in patients with asthma
Referral (1) Patients should be referred urgently for specialist care and investigation if the presenting headache is
accompanied by; suspected raised intracranial pressure, new onset seizure, focal neurological signs or
papilloedema
Outcome None
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Table 4 continued
Domain Sub-domain Quality indicator(s)
Leas et al. [12]
Diagnosis Investigations % of patients who had
(1) a computerized tomography scan
(2) a magnetic resonance imaging scan
Other % of patients
(1) who had a diagnosis of migraine
(2) who had a diagnosis of headache not otherwise specified
(iii) with a prescription for triptan who have a diagnosis of headache not otherwise specified
Treatment Acute % of patients who had a prescription for
(1) a triptan
(2) an ergot alkaloid/derivative
Prophylactic % of patients
(1) who had a prescription for a migraine preventive
(2) overusing triptans who have a prescription for migraine preventative
Other % patients who had
(1) a prescription for a triptan and a migraine preventative
(2) triptan overuse
Referral None
Outcome Uptake of care % of patients
(1) with at least 1 migraine-related emergency department visit who had a follow-up visit
(2) who had a primary-care physician visit for migraine (primary diagnosis)
(3) who had a primary-care physician visit for migraine (any diagnosis)
(4) who had a specialist visit for migraine
(5) who had an emergency department visit for migraine
(6) who had an acute hospitalization for migraine
and
Number of
(7) emergency department visits
(8) acute hospitalizations
(9) acute inpatient days
Ferrari et al. [11]
Diagnosis None
Treatment None
Referral None
Outcome Headache severity
and frequency
(1) % of chronic headache sufferers who reported a decrease of at least 50 % in headache frequency at
discharge from day hospital or ordinary hospital
(2) % of chronic headache sufferers overusing drugs who upon discharge from day hospital or ordinary
hospital after detoxifying therapy, reduce their intake of analgesics by at least 50 %
(3) % of patients re-admitted to day hospital or ordinary hospital within 28 days of discharge
(4) % of patients referred by their general practitioner for a clinical examination within 28 days of
discharge
(5) % of patients returning after discharge with side effects due to treatment prescribed
(6) % of patients returning after discharge owing to inefficacy of treatment prescribed
Uptake of care (1) % of patients with an appointment who do not turn up for their first clinical examination
(2) % of patients with an appointment who do not turn up for their examination to complete the
diagnostic picture
(3) No. of phone calls, fax messages, emails from general practitioners to the headache center
CT X-ray computerized tomography, MRI magnetic resonance imaging
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priority. Consensus on these issues is urgently required if
health care for headache—clearly suboptimal throughout the
world—is to be improved. This is a priority for patients and
for public health.
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